Allarity Therapeutics (ALLR) Non-Current Debt (2023)
Allarity Therapeutics' (ALLR) quarterly Non-Current Debt came in at $351000.0 in Q3 2023, little changed on a QoQ basis from $350000.0 in Q2 2023.
Allarity Therapeutics (ALLR) Non-Current Debt (2023) Analysis & Trends
Allarity Therapeutics (ALLR) has 1 years of Non-Current Debt data on file, last reported at $351000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 8.96 Bn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 351,000.00 |
| Jun 30, 2023 | 350,000.00 |